Th17 cells: A new therapeutic target in inflammatory dermatoses
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 19 (6), 318-326
- https://doi.org/10.1080/09546630802206660
Abstract
Th17 cells, named for their secretion of interleukin-17 (IL-17), are a new class of T-cells involved in a wide range of cutaneous autoimmune and inflammatory conditions. An overactive Th17 cell response in the skin can produce damaging results. There appears to be a partial role for the Th17 axis in the pathogenesis of a range of dermatological diseases including allergic contact dermatitis, atopic dermatitis, psoriasis, and scleroderma. Immunologists have also discovered a unique association between Th17 cells and cutaneous T-cell lymphoma. The Th17 branch has been linked to a number of additional systemic inflammatory diseases with significant cutaneous pathology such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, and Behcet's disease. Newly developed treatment modalities for neutralizing the Th17 branch of the immune system are proving to be valuable additions to the current therapeutic armamentarium.Keywords
This publication has 78 references indexed in Scilit:
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)The Lancet, 2008
- Th17 cells: A new paradigm for cutaneous inflammationJournal of Dermatological Treatment, 2008
- Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responsesThe Journal of Experimental Medicine, 2007
- Polymorphisms in Interleukin-15 Gene on Chromosome 4q31.2 Are Associated with Psoriasis Vulgaris in Chinese PopulationJournal of Investigative Dermatology, 2007
- IL-15 and Psoriasis: Another Genetic Link to Th17?Journal of Investigative Dermatology, 2007
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesAmerican Journal of Human Genetics, 2007
- Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array systemRheumatology, 2007
- Effect of glutathione S‐TRANSFERASE polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: Results from the roxbury lupus projectArthritis & Rheumatism, 2007
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisThe Journal of Experimental Medicine, 2006
- Atopic dermatitisJournal of the American Academy of Dermatology, 2005